Skip to main content

Epizyme, Inc.

EPZMDelisted Aug 12, 2022
Industry
Pharmaceutical Preparations
SEC CIK
0001571498

Epizyme, Inc. was delisted on Aug 12, 2022; its insiders filed their last Form 4 on Aug 16, 2022; 94 institutions reported holding it in 13F filings for Q2 2022, worth $187.0M in total; no superinvestor held it.

Holders of 5% or more of EPZM

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Epizyme, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Epizyme, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

21 Schedule 13D and 13G filings on Epizyme, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on EPZM
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 14, 2023Palo Alto Investors LP13G/AOld format–––SEC
Sep 8, 2022Primecap Management Co13G/AOld format–––SEC
Aug 15, 2022Ipsen, S.A.13D/AOld format–––SEC
Aug 9, 2022Primecap Management Co13G/AOld format–––SEC
Jul 7, 2022Ipsen, S.A.13DOld format–New–SEC
Jun 28, 2022RPI Finance Trust13D/AOld format–––SEC
Feb 14, 2022Palo Alto Investors LP13G/AOld format–––SEC
Feb 14, 2022Redmile Group, LLC13G/AOld format–––SEC
Feb 10, 2022Vanguard Group Inc13G/AOld format–––SEC
Feb 10, 2022Primecap Management Co13G/AOld format–––SEC
Feb 9, 20225:22 PM ETBlackRock Inc.13G/AOld format–––SEC
Feb 8, 2022Primecap Management Co13G/AOld format–––SEC
Feb 7, 20226:12 AM ETHUTCHMED (China) Ltd13D/AOld format–––SEC
Feb 3, 20224:41 PM ETBlackRock Inc.13G/AOld format–––SEC
Feb 1, 2022RPI Finance Trust13D/AOld format–––SEC
Aug 16, 20217:20 AM ETHUTCHMED (China) Ltd13DOld format–New–SEC
Feb 16, 2021Palo Alto Investors LP13G/AOld format–––SEC
Feb 16, 2021Redmile Group, LLC13G/AOld format–––SEC
Feb 12, 2021Primecap Management Co13G/AOld format–––SEC
Feb 10, 2021Vanguard Group Inc13G/AOld format–––SEC
Jan 29, 20219:56 AM ETBlackRock Inc.13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Epizyme, Inc. shares.

No Form 144 notices for Epizyme, Inc. are on file.